跳至主導覽 跳至搜尋 跳過主要內容

Complementary Chinese Herbal Medicine Therapy Improves Survival of Patients With Pancreatic Cancer in Taiwan: A Nationwide Population-Based Cohort Study

  • Yi Ting Kuo
  • , Hou Hsun Liao
  • , Jen Huai Chiang
  • , Mei Yao Wu
  • , Bor Chyuan Chen
  • , Ching Mao Chang
  • , Ming Hsien Yeh
  • , Tung Ti Chang
  • , Mao Feng Sun
  • , Chia Chou Yeh
  • , Hung Rong Yen*
  • *此作品的通信作者
  • China Medical University Taichung
  • Buddhist Tzu Chi Medical Foundation
  • Veterans General Hospital-Taipei
  • Tzu Chi University
  • Asia University Taiwan

研究成果: 期刊稿件 › 文章 › 同儕審查

59 引文 斯高帕斯(Scopus)

摘要

Background: Pancreatic cancer is a difficult-to-treat cancer with a late presentation and poor prognosis. Some patients seek traditional Chinese medicine (TCM) consultation. We aimed to investigate the benefits of complementary Chinese herbal medicine (CHM) among patients with pancreatic cancer in Taiwan. Methods: We included all patients with pancreatic cancer who were registered in the Taiwanese Registry for Catastrophic Illness Patients Database between 1997 and 2010. We used 1:1 frequency matching by age, sex, the initial diagnostic year of pancreatic cancer, and index year to enroll 386 CHM users and 386 non-CHM users. A Cox regression model was used to compare the hazard ratios (HRs) of the risk of mortality. The Kaplan-Meier curve was used to compare the difference in survival time. Results: According to the Cox hazard ratio model mutually adjusted for CHM use, age, sex, urbanization level, comorbidity, and treatments, we found that CHM users had a lower hazard ratio of mortality risk (adjusted HR = 0.67, 95% CI = 0.56-0.79). Those who received CHM therapy for more than 90 days had significantly lower hazard ratios of mortality risk than non-CHM users (90- to 180-day group: adjusted HR = 0.56, 95% CI = 0.42-0.75; >180-day group: HR = 0.33, 95% CI = 0.24-0.45). The survival probability was higher for patients in the CHM group. Bai-hua-she-she-cao (Herba Oldenlandiae; Hedyotis diffusa Spreng) and Xiang-sha-liu-jun-zi-tang (Costus and Chinese Amomum Combination) were the most commonly used single herb and Chinese herbal formula, respectively. Conclusions: Complementary Chinese herbal therapy might be associated with reduced mortality among patients with pancreatic cancer. Further prospective clinical trial is warranted.

原文英語
頁(從 - 到)411-422
頁數12
期刊Integrative Cancer Therapies
卷17
發行號2
DOIs
出版品狀態已出版 - 01 06 2018
對外發佈是

文獻附註

Publisher Copyright:
© 2017, © The Author(s) 2017.

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Complementary Chinese Herbal Medicine Therapy Improves Survival of Patients With Pancreatic Cancer in Taiwan: A Nationwide Population-Based Cohort Study」主題。共同形成了獨特的指紋。

引用此